期刊文献+

循环miRNA检测在诊断急性冠脉综合征中的意义 被引量:12

Circulating miRNA detection in the diagnosis of acute coronary syndrome
下载PDF
导出
摘要 目的:探讨循环miRNA检测在诊断急性冠脉综合征(ACS)中的意义。方法:选择100例ACS患者为研究组,匹配冠脉造影正常者100例为对照组,研究组再分为不稳定性心绞痛(UAP)组(n=32)和急性心肌梗死(AMI)组(n=68)。采用qRT-PCR方法检测血清miR-1,miR-133a,miR-208b,miR-499。结果:AMI患者的血清miR-1,miR-133a,miR-208b,miR-499水平较对照组显著增高,分别上调了4.15,4.46,7.95,6.62倍,UAP组较对照组也显著上升,分别上调了1.62,1.98,2.32,2.98倍,P均<0.05。4种miRNA在AMI患者中的变化曲线均表现为发病时显著升高,发病后6 h最高,发病后24 h,72 h显著下降,并接近正常水平。miR-1,miR-133a,miR-208b,miR-499对AMI患者诊断的ROC曲线下面积分别为0.68,0.75,0.80,0.73,介于肌酸激酶同工酶和肌钙蛋白T之间。结论:循环特异性miRNA的水平升高可用于辅助诊断ACS。 Objective: To investigate the circulating miRNA detection in the diagnosis of acute coronary syndrome. Methods: A total of 100 cases of ACS were collected for the study group, and 100 subjects of normal coronary angiography were matched for the control group. The study group was further divided into unstable angina (UAP) group (n = 32) and acute myocardial infarction (AMI) group ( n = 68 ). qRT-PCR was used to detect serum miR-1, miR-133a, miR-208b, miR-499. Results: Serum miR-1, miR-133a, miR-208b, miR-499 levels in AMI patients were significantly higher than the control group. They were increased 4.15,4.46, 7.95,6.62 fold (median, the same below). In UAP group, they were also increased significantly, 1.62, 1.98, 2.32, 2.98 fold compared with the control group respectively (P 〈 0.05). Four kinds of miRNA in AMI patients showed a change curve that was significantly improved after the onset of incidence, highest in 6 h and after the onset of 24 h, 72 h, decreased significantly and closed to the normal level. The area under the ROC curve of miR-1, miR-133a, miR-208b, miR-499 in patients with AMI were 0. 68 ,0. 75 ,0. 80,0. 73 , higher than CK-MB but lower than cTnT. Conclusion: Elevated levels of specific circulating miRNA can be used for the diagnosis of ACS.
出处 《江苏大学学报(医学版)》 CAS 2014年第1期59-62,共4页 Journal of Jiangsu University:Medicine Edition
关键词 急性冠脉综合征 MIRNA 诊断 acute coronary syndrome miRNA diagnosis
  • 相关文献

参考文献1

二级参考文献20

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.

共引文献981

同被引文献76

  • 1申华,周玉杰.2011欧洲心脏病学会非ST段抬高型急性冠脉综合征处理指南更新解读[J].中国医学前沿杂志(电子版),2011,3(5):97-99. 被引量:20
  • 2袁梅,周成芳,汤永红,袁海军.急性缺血性脑卒中患者血清miRNA-335表达水平及临床意义[J].中国动脉硬化杂志,2015,23(6):589-593. 被引量:20
  • 3Winter RJ,Koster RW,Sturk A,et al. Value of myo- globin,troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room [J]. Circulation, 1995,92 ( 12 ): 3401-3407.
  • 4Lewandrowski K, Chen A, Januzzi J. Cardiac markers for myocardial infarction a brief review[J]. Am J Clin Pathol, 2002,118 (Suppl 1 ) : S93-S99.
  • 5Gupta SK, Bang C,Thum T. Circulating mieroRNAs as biomarkers and potential paracrine mediators of cardiovascular disease [J]. Circ Cardiovasc Genet, 2010,3(5) :484-488.
  • 6Chen X,Zhana L,Su T,et al. Kinetics of plasma mi- cro RNA-499 expression in acute myocardial infarc- tion[J]. J Thorae Dis,2015,7 (5) : 890-896.
  • 7Whiting P,Rutjes AW,Reitsma JB,et al. The devel-opment of QUADAS: a tool for the quality assess- ment of studies of diagnostic accuracy included in sys- tematic reviews [J]. BMC Med Res Methodol, 2003 (3)..25.
  • 8Gidlof O, Smith JG, Miyazu K, et al. Circulating car dio-enriched microRNAs are associated with long term prognosis following myocardial infarction [J].BMC Cardiovase Disord,2013(13) : 12.
  • 9Wang H J, Zhang PJ, Chen WJ, et al. Four serum mi- croRNAs identified as diagnostic biomarkers of sep- sis[J]. J Trauma Acute Care Surg,2012,73(4):850- 854.
  • 10Olivieri F, Antonicelli R, I.orenzi M, et al. Diagnostic potential of circulating miR 499-5p in elderly pa- tients with acute non ST-elevation myocardial infarc- tion[J]. Int J Cardiol,2013,167(2):531-536.

引证文献12

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部